Press release
Primary Catalyst Driving Weight Loss Drugs Market Evolution in 2025: Rising Obesity Rates Fueling Surge in the Weight Loss Drugs Market Driver
Weight Loss Drugs Market
As obesity rates continue to rise, the market for weight loss drugs is projected to grow correspondingly. Obesity rates are determined by the percentage of the population with a Body Mass Index (BMI) of 30 or more. Weight loss medications, designed to combat obesity, facilitate weight reduction by suppress appetite, enhancing satiety, or preventing nutrient absorption. For example, the Centers for Disease Control and Prevention, a governmental organization from the US, reported in September 2023 that the obesity rate among adults had exceeded 35% in 19 states in 2021 and 22 states in 2022. Additionally, they noted that the prevalence of adult obesity was 35% or more in 2022. Moreover, according to a UK-based non-profit organization, the World Obesity Federation, their forecasts in March 2023 predicted more than 4 billion individuals to be obese by 2035. Hence, the upsurge in obesity rates is propelling the expansion of the weight loss drugs market.
Get Your Weight Loss Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
How will the growth rate of the weight loss drugs market shape industry trends by 2034?
The market for weight loss medications has seen substantial enlargement in the past few years. Its size, predicted to grow from $2.87 billion in 2024 to $4.23 billion in 2025, will experience a compound annual growth rate (CAGR) of 47.6%. Factors contributing to this growth in the historic period include an increase in obesity, shifts in lifestyle, heightened awareness and education, early detection of health conditions, and an escalation in healthcare spending.
The market size for weight loss drugs is predicted to experience significant expansion in the coming years, escalating to $17.08 billion in 2029 with a compound annual growth rate (CAGR) of 41.7%. Factors influencing this growth during the forecast period include the rise in elderly population, impacts of social media, trends in fitness and wellness, societal beauty standards, and investment in the pharmaceutical industry. Upcoming trends for the forecast period are technological progression, emphasis on over-the-counter solutions, customization in medicine, combination treatments, product innovation, and after-market monitoring.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp
What trends are poised to drive the future success of the weight loss drugs market?
In the weight loss drug market, key players are creating cutting-edge products like Zepbound (tirzepatide) injection to enhance patient care. Administered weekly, Zepbound is a combined agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. For example, in November 2023, FDA approval was granted to a pharmaceutical firm based in the US, Eli Lilly and Company, for their tirzepatide (Zebound) injection. This approval was for the chronic management of weight in adults who are overweight or obese and have at least one weight-related illness. With its unique mode of activating both GIP and GLP-1 receptors, Zebound holds promise for commercial success as the sole FDA-approved obesity treatment of its kind.
Which primary segments of the weight loss drugs market are driving growth and industry transformations?
The weight loss drugs market covered in this report is segmented -
1) By Type: Liquid, Tablets, Capsules
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters
Subsegments:
1) By Liquid: Syrups, Solutions, Suspensions
2) By Tablets: Immediate-Release Tablets, Extended-Release Tablets
3) By Capsules: Hard Capsules, Softgel Capsules
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13761
North America was the largest region in the Weight Loss Drugs market in 2024. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the weight loss drugs market landscape?
Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca PLC, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd., Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13761&type=smp
What Is Covered In The Weight Loss Drugs Global Market Report?
•Market Size Forecast: Examine the weight loss drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the weight loss drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the weight loss drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the weight loss drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the weight loss drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the weight loss drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the weight loss drugs market.
•Competitive Landscape: Review strategic developments in the weight loss drugs market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving Weight Loss Drugs Market Evolution in 2025: Rising Obesity Rates Fueling Surge in the Weight Loss Drugs Market Driver here
News-ID: 3922499 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
